Drug Trial Radar · NCT05680415
Clinical Trial of Mica
Last checked: Nov 20, 2026Latest source record: Jun 25, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
6,800
Planned (sponsor's estimate)
Start
Apr 19, 2023
Primary completion
Sep 30, 2026
Study completion Aug 31, 2027
Sponsor
- Lead sponsor
- Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jan 11, 2023
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 15 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study used a randomized, open, blank control design. A total of 6800 patients over 15 years old with latent mycobacterium tuberculosis infection who met the inclusion criteria but did not meet the exclusion criteria were randomly assigned to the experimental group and the blank control group in a 1:1 ratio, with 3400 patients in each group. The experimental group was alternately injected with 1 dose of microcard every two weeks (0-2-4-6-8-10 weeks) in the left and right hip muscle deep, with a total of 6 doses. The blank control group was not injected with drugs.
Conditions
- Latent Tuberculosis Infection
Interventions
Mycobacterium Vaccae for InjectionBiological
The experimental group was alternately injected with 1 dose of microcard every two weeks (0-2-4-6-8-10 weeks) in the left and right hip muscle deep, and a total of 6 doses were injected.
Primary outcomes
What the sponsor says the trial is designed to measure.
- End point of efficacyTime frame: through study completion, an average of 2 year
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Liujiang district Prevention and Control center
Liuzhou, Guangxi, China
Liuzhou Center for Disease Control and Prevention
Liuzhou, Guangxi, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.